论文部分内容阅读
为评估天津市MTB与HIV双重感染项目防治效果,完善我市双重感染患者的治疗和管理机制,笔者选取2011年6月1日至201 6年12月31日全国结核病专报系统中登记的天津市1 9 564例结核病患者作为调查对象进行分析.其中16 821例接受了HIV检测,发现并确诊42例为MTB与HIV双重感染患者.对双重感染者给予抗结核(42例)和抗HIV病毒(32例)药物治疗,观察患者治疗、转归情况并跟踪随访1年.结果显示,结核病患者中HIV筛查率为86.0％(1 6 821/19 564),HIV阳性检出率为0.25％(42/16 821).对双重感染患者抗结核药物治疗的成功率为78.6％(33/42);有32例接受了抗HIV病毒治疗,占76.2％(32/42).1年后对33例结核病治疗成功的患者随访,有4例死亡,2例结核病复发.“,”To assess the effect of TB/HIV co-infection control program in Tianjin and to provide scientific evidence for the improvement of treatment and management mechanism of TB/HIV cc-infection.A total of 19 654 tuberculosis patients registered in the Tuberculosis Information Management System from June 2011 to December 2016 were enrolled,of which 16 821 received HIV test and 42 patients with TB and HIV co-infection were confirmed.We provided anti-TB treatment (42 cases) and anti-retroviral-therapy (ART) (32 cases) for patients with TB/HIV co-infection and observed their treatment outcomes and followed up for one year.HIV screening rate among TB patients was 86.0％ (16 821/19 564) and HIV positive rate was 0.25％ (42/16 821).TB treatment success rate was 78.6％ (33/42),32 (76.2％) received ART.Among 33 patients of TB treatment success,4 was died and 2 relapsed within one-year follow up.